Cite
Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial
MLA
Claire Watkins, et al. “Comparison of Rosuvastatin with Atorvastatin, Simvastatin and Pravastatin in Achieving Cholesterol Goals and Improving Plasma Lipids in Hypercholesterolaemic Patients with or without the Metabolic Syndrome in the MERCURY I Trial.” Diabetes, Obesitymetabolism, vol. 7, no. 4, June 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2af22a70886445198064afe694fa04cc&authtype=sso&custid=ns315887.
APA
Claire Watkins, Philip J. Barter, Steen Stender, Herbert Schuster, & David Kallend. (2005). Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Diabetes, Obesitymetabolism, 7(4).
Chicago
Claire Watkins, Philip J. Barter, Steen Stender, Herbert Schuster, and David Kallend. 2005. “Comparison of Rosuvastatin with Atorvastatin, Simvastatin and Pravastatin in Achieving Cholesterol Goals and Improving Plasma Lipids in Hypercholesterolaemic Patients with or without the Metabolic Syndrome in the MERCURY I Trial.” Diabetes, Obesitymetabolism 7 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2af22a70886445198064afe694fa04cc&authtype=sso&custid=ns315887.